Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
2.080
-0.050 (-2.35%)
At close: Apr 28, 2026, 4:00 PM EDT
2.167
+0.087 (4.18%)
After-hours: Apr 28, 2026, 4:38 PM EDT
Caribou Biosciences Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Caribou Biosciences stock have an average target of 10.75, with a low estimate of 8.00 and a high estimate of 13. The average target predicts an increase of 416.83% from the current stock price of 2.08.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Caribou Biosciences stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +332.69% | Apr 7, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $11 → $13 | Buy | Maintains | $11 → $13 | +525.00% | Mar 9, 2026 |
| Clear Street | Clear Street | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +525.00% | Feb 2, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $9 | Strong Buy | Maintains | $3 → $9 | +332.69% | Nov 5, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $5 → $8 | Strong Buy | Maintains | $5 → $8 | +284.62% | Nov 3, 2025 |
Financial Forecast
Revenue This Year
11.34M
from 11.16M
Increased by 1.63%
Revenue Next Year
12.58M
from 11.34M
Increased by 10.93%
EPS This Year
-1.24
from -1.59
EPS Next Year
-1.35
from -1.24
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 12.6M | 15.8M | ||||||
| Avg | 11.3M | 12.6M | ||||||
| Low | 9.8M | 11.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 12.9% | 38.9% | ||||||
| Avg | 1.6% | 10.9% | ||||||
| Low | -12.2% | -1.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.79 | -0.78 | |||
| Avg | -1.24 | -1.35 | |||
| Low | -1.50 | -1.50 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.